c-Abl is a nonreceptor tyrosine kinase that is activated by certain DNA-damaging agents. The present studies demonstrate that nuclear c-Abl binds constitutively to the protein tyrosine phosphatase SHPTP1. Treatment with ionizing radiation is associated with c-Abl-dependent tyrosine phosphorylation of SHPTP1. The results demonstrate that the SH3 domain of c-Abl interacts with a WPDHGVPSEP motif (residues 417-426) in the catalytic domain of SHPTP1 and that c-Abl phosphorylates C terminal Y536 and Y564 sites. The functional significance of the c-Abl-SHPTP1 interaction is supported by the demonstration that, like c-Abl, SHPTP1 regulates the induction of Jun kinase activity following DNA damage. These findings indicate that SHPTP1 is involved in the response to genotoxic stress through a c-Abl-dependent mechanism.
Eukaryotic cells respond to ionizing radiation (IR) with cell cycle arrest, activation of DNA repair, and apoptosis. These responses are induced by direct interaction of IR with DNA or through the formation of hydroxyl radicals and superoxides (1, 2) . However, the signaling cascades that are activated by IR-induced damage remain unclear. The finding that IR activates transcription of the c-jun and EGR-1 early response genes (3) (4) (5) has supported involvement of nuclear signals. The nuclear factor KB and the tumor suppressor p53 are also activated by IR exposure (6, 7) . IR-induced activation of these DNA binding proteins presumably represents early nuclear signals that regulate longer-term changes in gene expression, which constitute the IR response.
Several insights are available regarding protein kinases that transduce IR-induced signals in the nucleus. IR treatment is associated with induction of the mitogen-activated protein kinase and ppgorsk (8) . Other studies have demonstrated that IR induces the stress-activated protein kinase (SAPK, Jun N-terminal kinase) (9) (10) (11) . Both mitogen-activated protein kinase and SAPK can stimulate the transactivating potential of c-Jun by phosphorylation of S-63 and S-73 sites (12) (13) (14) . SAPK is related to mitogen-activated protein kinase and, while unable to phosphorylate ppgOrsk, it is more active in phosphorylating c-Jun. The finding that SAPK phosphorylates Elk-1 (15) suggests that SAPK may also contribute to IR-induced EGR-1 transcription through activation of serum response elements (5) . SAPK is regulated by the SAPK/ERK kinase 1 (16, 17) . SAPK/ERK kinase 1 may thus link IR-induced signals to SAPK and thereby activation of c-jun and EGR-1 transcription.
Recent studies have demonstrated that IR activates the nuclear c-Abl protein tyrosine kinase (18) . The finding that cells deficient in c-Abl fail to activate SAPK in response to IR-treatment has supported c-Abl as an upstream signal in this stress response. Other studies have shown that c-Abl binds to p53 in vitro and stimulates the transactivation function of p53 (19) . Overexpression of c-Abl also induces the arrest of cells in Gi phase (20, 21) . Because IR treatment is associated with Gi arrest, c-Abl activation could play a role in regulating both this response and induction of SAPK.
The present studies have addressed the involvement of other c-Abl-associated signals in the IR response. The results demonstrate that IR induces c-Abl-dependent phosphorylation of the protein tyrosine phosphatase SHPTP1 (22, 23) . We also show that SHPTP1 is involved in regulation of the c-Abl SAPK cascade in IR-treated cells.
MATERIALS AND METHODS
Cell Culture. Human U-937 myeloid leukemia cells (American Type Culture Collection) were grown as described (9) . Abl-/-(24), Abl+ (18) , and NIH 3T3 fibroblasts were grown in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum. Irradiation was performed at room temperature using a Gammacell 1000 (Atomic Energy of Canada, Ottawa, Ontario) under aerobic conditions, with a '37Cs source emitting at a fixed dose rate of 0.76 Gy min-' as determined by dosimetry.
Preparation of Nuclear Lysates. Cells were swelled in 2 ml of ice-cold hypotonic lysis buffer (1 mM EGTA/1 mM EDTA/10 mM P3-glycerophosphate/2 mM MgCl2/10 mM KCl/1 mM sodium orthovanadate/1 mM phenylmethylsulfonyl fluoride/i mM DTT/10 ,tg each of pepstatin, leupeptin, and aprotinin per ml) for 30 min and then subjected to Dounce homogenization (15-25 strokes, tight pestle A). The resulting lysate was loaded onto 1.5 ml of buffer A (1 M sucrose in hypotonic lysis buffer) and centrifuged at 1600 x g for 15 min to pellet nuclei. The pellet was washed and solubilized in lysis buffer containing 1% (vol/vol) Nonidet P-40.
Immunoprecipitation and -Immunoblot Analysis. Immunoprecipitation was performed as described (9) . In brief, soluble proteins (200 ,g) were incubated with anti-Abl (K-12, Santa Cruz Biotechnology), anti-SHPTP1 (Upstate Biotechnology), or anti-P-Tyr (Upstate Biotechnology) for 1 h and precipitated with protein A-Sepharose for an additional 1 h. The resulting immune complexes were washed three times with lysis buffer, separated by electrophoresis in SDS/polyacrylamide gels, and then transferred to nitrocellulose paper. The residual binding sites were blocked by incubating the filters with 5% dry milk in phosphate-buffered saline and 0.05% Tween 20 for 1 h at room temperature. The filters were incubated with anti-Abl, anti-SHPTP1, or anti-P-Tyr for 1 h with shaking. After washing twice with phosphate-buffered saline and 0.05% Tween 20, the blots were incubated with anti-rabbit IgG peroxidase conjugate (Amersham). The antigen antibody comAbbreviations: IR, ionizing radiation; SAPK, stress-activated protein kinase.
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plexes were visualized by enhanced chemiluminescence (ECL detection system, Amersham).
Fusion Protein Binding Assays. GST and GST-Abl SH3 (25) were purified by affinity chromatography using glutathioneSepharose beads and equilibrated in lysis buffer. Cell lysates were incubated with 2 jig of immobilized GST or GST-Abl SH3 for 2 h at 4°C. The resulting protein complexes were washed three times with lysis buffer containing 0.1% detergent and boiled for 5 min in SDS sample buffer. The complexes were then separated by SDS/PAGE and subjected to immunoblot analysis with anti-SHPTP1 kinase antibody.
Immune (Fig. 1A) . In the reciprocal experiment, analysis of anti-SHPTP1 immunoprecipitates with anti-Abl confirmed a constitutive association between these two proteins (Fig. 1B) . Analysis of anti-SHPTP1 immunoprecipitates with anti-P-Tyr further demonstrated IR-dependent increases in tyrosine phosphorylation of SHPTP1 (Fig. 1C) . Recent studies have shown that nuclear c-Abl is activated in cells exposed to IR or certain alkylating agents (18) . To determine whether c-Abl is involved in the regulation of SHPTP1, mouse fibroblasts deficient in c-Abl (Abl-/-; derived from mice with targeted c-Abl disruption) (24) were assayed for SHPTP1 phosphorylation. In the Abl-/-cells, there was no detectable increase in tyrosine phosphorylation of SHPTP1 following exposure to IR (Fig. 1D) . In contrast, reconstituted Abl-/-cells that stably express c-Abl (designated Abl+) were found to respond to IR with increases in tyrosine phosphorylation of SHPTP1 (Fig. 1D) . Taken together, these results provide evidence that the response to IR includes c-Abl-dependent tyrosine phosphorylation of
SHPTP1.
The association between c-Abl and SHPTP1 was further analyzed by incubating U-937 cell lysates with a GST fusion protein prepared from the c-Abl SH3 domain. Adsorbates obtained with GST-Abl SH3, but not with GST, revealed binding of SHPTP1 (Fig. 24) . There was also no detectable binding of SHPTP1 to the C-terminal SH3 domain of the Grb2 adaptor protein (data not shown). To determine whether the interaction between c-Abl and SHPTP1 is direct, we incubated A. (Fig. 2B ). While these findings support direct binding, purified SHPTP1 was subjected to SDS/PAGE, transferred to nitrocellulose, and then incubated with GSTAbl SH3 or GST. Analysis of adsorbed protein with anti-GST demonstrated binding of c-Abl SH3 and not GST (Fig. 2C) . Other studies have shown that the c-Abl SH3 domain binds to a proline-rich sequence with the consensus XPXXXXPXXP (25, 26) . A potential sequence for c-Abl SH3 binding is present in SHPTP1 (amino acids 417-426; WPDHGVPSEP). To confirm binding of c-Abl to this site, we mutated prolines at positions 418 and 423 to alanine (WADHGVASEP) and asked whether this mutant interacts with GST-Abl SH3. The mutant protein is readily cleaved to a 46-kDa C-terminal fragment without SH2 domains (ASH2 P418A/P423A). A similar protein has been described for wild-type SHPTP1 that contains the WADHGVPSEP sequence and not the SH2 domains (ASH2 SHPTP1) (22) . The finding that binding of the c-Abl SH3 domain to the ASH2 P418A/P423A mutant is decreased compared with that obtained with ASH2 SHPTP1 supports interaction through the WPDHGVPSEP motif (Fig. 2D) .
SHPTP1 contains two N-terminal SH2 domains, the protein tyrosine phosphatase domain and a C terminus, which includes potential tyrosine phosphorylation sites (22) . One of these sites (Y-564) is phosphorylated in T cells as a result of Lck activation (27) . To determine whether and where c-Abl phosphorylates SHPTP1, we incubated anti-Abl immunoprecipitates from control and IR-treated cells with equal amounts of recombinant SHPTP1 protein (residues 1-595) (23) and [,y-32P]ATP. Autoradiography of the reaction products demonstrated increased tyrosine phosphorylation of SHPTP1 (Fig. 3A) . To been truncated of the last 60 amino acids (23) . While this mutant failed to serve as a substrate, a AC35 mutant (1-560) (23) was phosphorylated by c-Abl (Fig. 3B) , allowing focus on the potential tyrosine phosphorylation sites in the C-terminal region of SHPTP1 (Y536, Y541, and Y564). Mutation of Y536 to F failed to block phosphorylation (Fig. 3C) . Similar results were obtained with the Y541F, Y564F, and Y541F/Y564F mutants. In contrast, there was no detectable phosphorylation of the Y536F/Y564F double mutant (Fig. 3C) . These findings establish that c-Abl phosphorylates both the Y536 and Y564 sites. We also incubated purified c-Abl with ASH2 SHPTP1 and the ASH2 P418A/P423A mutant. The finding that c-Abl phosphorylates wild-type SHPTP1 more efficiently than the mutant supports involvement of c-Abl binding to the WPDH-GVPSEP site before the phosphorylation reaction (Fig. 3D) .
The present findings thus provide evidence that SHPTP1 is a substrate for c-Abl. Because c-Abl is activated by certain DNA-damaging agents and contributes to activation of SAPK (18), we asked whether SHPTP1 is involved in regulation of this stress pathway. To address this issue, we transfected NIH 3T3 cells with pEBG-SAPK (17) and, after IR exposure, assayed glutathione-Sepharose protein precipitates for phosphorylation of Jun (Fig. 4A) . Cotransfection of pEBG-SAPK and wild-type SHPTP1 blocked IR-induced activation of SAPK (Fig. 4A) . In contrast, IR-induced SAPK activity was stimulated by cotransfection of a dominant negative SHPTP1, which expresses a C453S mutant (23) (Fig. 4A) .
Few insights are available regarding the functional role of c-Abl. Interaction of the c-Abl SH1 domain with the retinoblastoma protein (Rb) has been reported to inhibit c-Abl kinase activity (28) , while the c-Abl SH2 domain has been of SH3-containing adaptor proteins (25, 26) . Other studies have demonstrated that Abl-interactor proteins 1 and 2 constitutively bind to the SH3 and carboxy-terminal domains of c-Abl and suppress its transforming activity (30, 31) . The present finding that the SH3 domain of c-Abl also binds constitutively to SHPTP1 supports the existence of distinct c-Abl pools. The present results also indicate that c-Abl phosphorylates SHPTP1 in vivo in an IR-dependent fashion. Moreover, the finding that SHPTP1 downregulates IRinduced SAPK activation further supports a role for SHPTP1 as a negative regulator of the c-Abl->SAPK cascade in the response to genotoxic stress (Fig. 4B) 
